Fluence LED has been selected to enable Acceleration Platform for Innovation, a program that helps companies participate in research that advances medical cannabis production in EMEA.Fluence, a leading global provider of energy-efficient LED lighting solutions for commercial cannabis and food production, announced an expansion of its research collaboration with Dutch organization Innexo BV (Innexo), a specialist agricultural independent research organization focused on molecular agriculture and medicinal plants.

By the first of January 2023, current director Peter Korsten will be handing over the directorship of Botany and Exploras to his successor Maarten Vliex. In recent years, the Botany Group has grown significantly. The group currently consists of seven different companies, each with its own specialization and managing director. Until recently, Peter Korsten, in addition to being the group managing director of Botany Group, was also managing director of companies Botany and Exploras. This will change on the first of January 2023. On this date he will transfer the directorship to Maarten Vliex.

Since April 1st, Innexo BV is officially licensed by the Dutch Government through the Medical Cannabis Agency to conduct research on cannabis plants for scientific purposes. After a successful audit by the Inspectorate for Healthcare and Youth (IGJ), Innexo is able focus on legal cannabis cultivation research for the next 5 years. Managing Director and co-owner of Innexo, Dominique van Gruisen, is very pleased with this evolution: "This is an important milestone. Not only for the company, but for everybody involved in the medical cannabis industry. We can now help companies that are active in the fields of technological development, genetic exploration, system builders, suppliers and licensed producers, to innovate in cannabis cultivation. More importantly, the research we conduct is practically oriented (applied research) and is independent. We are not producers, we are practically oriented researchers with many years of experience in medicinal plants. Through this license, we can partner with industry leaders to advance the much needed research in the production of cannabis for medical purposes."